The estimated cost for a 30-day supply of brand-name Crestor in the United States in 2026 is not publicly available. Drug pricing is influenced by various factors, including patent exclusivity, manufacturing costs, and market demand.
When Does Crestor Patent Exclusivity End?
The patent exclusivity for Crestor (rosuvastatin calcium) has largely expired in major markets, including the U.S. [1]. This typically leads to the introduction of generic versions of the medication.
What is the Cost of Generic Rosuvastatin?
Following patent expiry, generic versions of Crestor, known as rosuvastatin, become available. The cost of generic rosuvastatin is significantly lower than the brand-name drug. Prices can vary widely depending on the pharmacy, insurance coverage, and dosage. For example, a 30-day supply of generic rosuvastatin can range from around $10 to $50 or more, whereas brand-name Crestor was considerably more expensive [2].
Will Crestor Still Be Available in 2026?
Brand-name Crestor may still be available in 2026, but generic rosuvastatin will be the more prevalent and cost-effective option. Pharmaceutical companies sometimes continue to market brand-name drugs even after generic competition emerges, though their market share and price tend to decrease.
How Can I Find Current Drug Prices?
To find current pricing for rosuvastatin or any medication, it is recommended to check with local pharmacies, use online pharmacy price comparison tools, or consult your insurance provider. Websites like DrugPatentWatch.com provide information on drug patents and exclusivity periods, which can help understand pricing trends [3].